P04.1
Non-billableNewborn affected by other maternal medication
Newborn affected by other maternal medication
This is a header/category code. For billing purposes, use a more specific child code from the list below.
Coding Notes
Includes
Conditions included under this code
- conditions that have their origin in the fetal or perinatal period (before birth through the first 28 days after birth) even if morbidity occurs later
- nonteratogenic effects of substances transmitted via placenta
Excludes 1
Codes that cannot be used together with this code (mutual exclusion)
Excludes 2
Conditions not included here, but the patient may have both
- •congenital malformations, deformations and chromosomal abnormalitiesQ00-Q99
- •endocrine, nutritional and metabolic diseasesE00-E88
- •injury, poisoning and certain other consequences of external causesS00-T88
- •neoplasmsC00-D49
- •tetanus neonatorumA33
- •congenital malformationsQ00-Q99
- •encounter for observation of newborn for suspected diseases and conditions ruled outZ05
- •neonatal jaundice from excessive hemolysis due to drugs or toxins transmitted from motherP58.4
- •newborn in contact with and (suspected) exposures hazardous to health not transmitted via placenta or breast milkZ77
- •maternal anesthesia and analgesia in pregnancy, labor and deliveryP04.0
- •maternal use of drugs of addictionP04.4
Code First
The underlying condition must be sequenced before this code
- any current condition in newborn, if applicable
- •, if applicable, withdrawal symptoms from maternal use of drugs of addictionP96.1
- •withdrawal symptoms from therapeutic use of drugs in newbornP96.2
Child Codes (10)
P04.11Newborn affected by maternal antineoplastic chemotherapy
P04.12Newborn affected by maternal cytotoxic drugs
P04.13Newborn affected by maternal use of anticonvulsants
P04.14Newborn affected by maternal use of opiates
P04.15Newborn affected by maternal use of antidepressants
P04.16Newborn affected by maternal use of amphetamines
P04.17Newborn affected by maternal use of sedative-hypnotics
P04.18Newborn affected by other maternal medication
P04.19Newborn affected by maternal use of unspecified medication
P04.1ANewborn affected by maternal use of anxiolytics
Related Codes(8)
P04.0NB aff by matern anesth and analgesia in preg, labor and del
P04.2Newborn affected by maternal use of tobacco
P04.3Newborn affected by maternal use of alcohol
P04.4Newborn affected by maternal use of drugs of addiction
P04.5Newborn aff by maternal use of nutritional chemical substnc
P04.6Newborn aff by maternal exposure to environ chemical substnc
P04.8Newborn affected by other maternal noxious substances
P04.9Newborn affected by maternal noxious substance, unspecified
ICD-11 Equivalents(1)
ICD-11 Equivalents
View full mappingCorresponding ICD-11 codes from the WHO crosswalk mapping
Also Known As / Clinical Terms(1)
Frequently Asked Questions
What is the ICD-10 code for newborn affected by other maternal medication?
The ICD-10-CM code for newborn affected by other maternal medication is P04.1. The full clinical description is "Newborn affected by other maternal medication". P04.1 is a non-billable header code. Use a more specific child code for billing purposes.
What does ICD-10 code P04.1 mean?
ICD-10-CM code P04.1 represents “Newborn affected by other maternal medication”. It is classified under Chapter 16: Certain Conditions Originating in the Perinatal Period and is a non-billable header code. Use a more specific child code for billing purposes.
Is P04.1 a billable code?
No, P04.1 is a non-billable header code. You need to use one of its more specific child codes for billing. There are 10 child codes under P04.1.
What chapter is P04.1 in?
P04.1 is in Chapter 16: Certain Conditions Originating in the Perinatal Period (codes P00-P96).
What codes cannot be used with P04.1?
P04.1 has Excludes1 notes indicating codes that cannot be used together with it, including: dysmorphism due to warfarin (Q86.2); fetal hydantoin syndrome (Q86.1).
What are the subcategories under P04.1?
P04.1 has 10 child codes, including: P04.11 (Newborn affected by maternal antineoplastic chemotherapy), P04.12 (Newborn affected by maternal cytotoxic drugs), P04.13 (Newborn affected by maternal use of anticonvulsants), P04.14 (Newborn affected by maternal use of opiates), and 6 more.
What are the UMLS CUIs for P04.1?
P04.1 is linked to 1 UMLS Concept Unique Identifier: C4269121. The UMLS (Unified Medical Language System) integrates multiple biomedical vocabularies maintained by the U.S. National Library of Medicine.
How does P04.1 relate to ICF functioning codes?
ICF (International Classification of Functioning, Disability and Health) codes describe how conditions like newborn affected by other maternal medication affect a person's functioning — body functions, activities, participation, and environmental factors. AutoICD provides ICF Core Sets for 12+ conditions and can map clinical text to ICF categories automatically. Browse the ICF directory to explore functioning codes.
What is the ICD-11 equivalent of P04.1?
P04.1 maps to the ICD-11 code: KA06.Y (Fetus or newborn affected by other specified noxious influence transmitted via placenta or breast milk).
Automate ICD-10 Coding With AI
Send clinical text to the AutoICD API and get back structured ICD-10 codes with confidence scores. Integrates into any EHR or billing system in minutes.
Includes SNOMED Clinical Terms® (SNOMED CT®) used by permission of SNOMED International. Includes content from the UMLS Metathesaurus, courtesy of the U.S. National Library of Medicine.